The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Antifungal Prophylaxis in Cancer Patients After Chemotherapy or Hematopoietic Stem-Cell Transplantation: Systematic Review and Meta-Analysis
Abstract
Purpose: To evaluate the effect of antifungal prophylaxis on all-cause mortality as primary outcome, invasive fungal infections (IFIs), and adverse events. Many studies have evaluated the role of antifungal prophylaxis in cancer patients, with inconsistent conclusions. Methods: We performed a systematic review and meta-analysis of randomized, controlled trials comparing systemic antifungals with placebo, no intervention, or other antifungal agents for prophylaxis in cancer patients after chemotherapy. The Cochrane Library, MEDLINE, conference proceedings, and references were searched. Two reviewers independently appraised the quality of trials and extracted data. Results: Sixty-four trials met inclusion criteria. Antifungal prophylaxis decreased all-cause mortality significantly at end of follow-up compared with placebo, no treatment, or nonsystemic antifungals (relative risk [RR], 0.84; 95% CI, 0.74 to 0.95). In allogeneic hematopoietic stem-cell transplantation (HSCT) recipients, prophylaxis reduced all-cause mortality (RR, 0.62; 95% CI, 0.45 to 0.85), fungal-related mortality, and documented IFI. In acute leukemia patients, there was a significant reduction in fungal-related mortality and documented IFI, whereas the difference in mortality was only borderline significant (RR, 0.88; 95% CI, 0.74 to 1.06). Prophylaxis with itraconazole suspension reduced documented IFI when compared with fluconazole, with no difference in survival, and at the cost of more adverse events. On the basis of two studies, posaconazole prophylaxis reduced all-cause mortality (RR, 0.74; 95% CI, 0.56 to 0.98), fungal-related mortality, and IFI when compared with fluconazole. Conclusion: Antifungal prophylaxis decreases all-cause mortality significantly in patients after chemotherapy. Antifungal prophylaxis should be administered to patients undergoing allogeneic HSCT, and should probably be administered to high-risk acute leukemia patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331
Bucher, H. C., Guyatt, G. H., Griffith, L. E., & Walter, S. D. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00049-8 · Cited by 2,052
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.-T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,813
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
Lin, S.-J., Schranz, J., & Teutsch, S. M. (2001) · Clinical Infectious Diseases · doi:10.1086/318483 · Cited by 1,409
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P., Langston, A., Tarantolo, S. R., Greinix, H., Morais de Azevedo, W., Reddy, V., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,345
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174
Slavin, M. A., Osborne, B., Adams, R., Levenstein, M. J., Schoch, H. G., Feldman, A. R., Meyers, J. D., & Bowden, R. A. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1545 · Cited by 820
van Burik, J.-A. H., Ratanatharathorn, V., Stepan, D. E., Miller, C. B., Lipton, J. H., Vesole, D. H., Bunin, N., Wall, D. A., Hiemenz, J. W., Satoi, Y., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/422312 · Cited by 744
Invasive Fungal Pathogens: Current Epidemiological Trends
Pfaller, M. A., Pappas, P. G., & Wingard, J. R. (2006) · Clinical Infectious Diseases · doi:10.1086/504490 · Cited by 448
Marr, K. A., Crippa, F., Leisenring, W., Hoyle, M., Boeckh, M., Balajee, S. A., Nichols, W. G., Musher, B., & Corey, L. (2004) · Blood · doi:10.1182/blood-2003-08-2644 · Cited by 442
Winston, D. J., Maziarz, R. T., Chandrasekar, P. H., Lazarus, H. M., Goldman, M., Blumer, J. L., Leitz, G. J., & Territo, M. C. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-9-200305060-00006 · Cited by 389
Winston, D. J., Chandrasekar, P. H., Lazarus, H. M., Goodman, J. L., Silber, J. L., Horowitz, H., Shadduck, R. K., Rosenfeld, C. S., Ho, W. G., Islam, M. Z., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00003 · Cited by 373
Rotstein, C., Bow, E. J., Laverdiere, M., Ioannou, S., Carr, D., Moghaddam, N., & The Canadian Fluconazole Prophylaxis Study Group (1999) · Clinical Infectious Diseases · doi:10.1086/515128 · Cited by 265
Glasmacher, A., Prentice, A., Gorschlüter, M., Engelhart, S., Hahn, C., Djulbegovic, B., & Schmidt-Wolf, I. G. H. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.052 · Cited by 264
Bow, E. J., Laverdière, M., Lussier, N., Rotstein, C., Cheang, M. S., & Ioannou, S. (2002) · Cancer · doi:10.1002/cncr.10610 · Cited by 258
Menichetti, F., Del Favero, A., Martino, P., Bucaneve, G., Micozzi, A., Girmenia, C., Barbabietola, G., Pagano, L., Leoni, P., Specchia, G., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/515129 · Cited by 244
Benjamin, D. K., Driscoll, T., Seibel, N. L., Gonzalez, C. E., Roden, M. M., Kilaru, R., Clark, K., Dowell, J. A., Schranz, J., & Walsh, T. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.632-638.2006 · Cited by 210
van Burik, J.-A. H., Leisenring, W., Myerson, D., Hackman, R. C., Shulman, H. M., Sale, G. E., Bowden, R. A., & McDonald, G. B. (1998) · Medicine · doi:10.1097/00005792-199807000-00003 · Cited by 205
Morgenstern, G. R., Prentice, A. G., Grant Prentice, H., Ropner, J. E., Schey, S. A., Warnock, D. W., & on behalf of the U.K. Multicentre Antifungal Prophylaxis Study Group (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01465.x · Cited by 201
Towards a targeted, risk‐based, antifungal strategy in neutropenic patients
Prentice, H. G., Kibbler, C. C., & Prentice, A. G. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02014.x · Cited by 181
Epstein, J. B., Vickars, L., Spinelli, J., & Reece, D. (1992) · Oral Surgery, Oral Medicine, Oral Pathology · doi:10.1016/0030-4220(92)90009-f · Cited by 179
Kelsey, S., Goldman, J., McCann, S., Newland, A., Scarffe, J., Oppenheim, B., & Mufti, G. (1999) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701543 · Cited by 173
(2001) · Cytotherapy · doi:10.1080/146532401753156403 · Cited by 172
Prophylactic Intravenous Amphotericin B in Neutropenic Autologous Bone Marrow Transplant Recipients
Perfect, J. R., Klotman, M. E., Gilbert, C. C., Crawford, D. D., Rosner, G. L., Wright, K. A., & Peters, W. P. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/165.5.891 · Cited by 171
Mattiuzzi, G. N., Alvarado, G., Giles, F. J., Ostrosky-Zeichner, L., Cortes, J., O'Brien, S., Verstovsek, S., Faderl, S., Zhou, X., Raad, I. I., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.143-147.2006 · Cited by 168
Schwartz, S., Behre, G., Heinemann, V., Wandt, H., Schilling, E. C., Arning, M., Trittin, A., Kern, W. V., Boenisch, O., Bosse, D., et al. (1999) · PubMed · doi:10.1182/blood.v93.11.3654 · Cited by 165
Tollemar, J. G., Ringdén, O. T. H., Andersson, S., Sundberg, B., Ljungman, P. T., & Tydén, G. (1993) · PubMed · Cited by 162
Prophylactic action of oral fluconazole against fungal infection in neutropenic patients
Kanda, Y., Yamamoto, R., Chizuka, A., Hamaki, T., Suguro, M., Arai, C., Matsuyama, T., Takezako, N., Miwa, A., Kern, W., et al. (2000) · Cancer · doi:10.1002/1097-0142(20001001)89:7<1611::aid-cncr27>3.0.co;2-b · Cited by 154
Harousseau, J., Dekker, A. W., Stamatoullas, A., Fassas, Α., Linkesch, W., Gouveia, J., Bock, R. D., Rovira, M., Seifert, W., Joosen, H., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1887-1893.2000 · Cited by 151
Hiemenz, J., Cagnoni, P. J., Simpson, D., Devine, S. M., Chao, N. J. A., Keirns, J. J., Lau, W. M., Facklam, D., & Buell, D. N. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1331-1336.2005 · Cited by 150
Hann, I. M., Corringham, R. E., Keaney, M. G. L., Noone, P., Fox, J., Szawatkowski, M., Prentice, H. G., Blacklock, H. A., Shannon, M. S., Gascoigne, E. W., et al. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91874-8 · Cited by 150
Menichetti, F., Favero, A. D., Martino, P., Bucaneve, G., Micozzi, A., D'Antonio, D., Ricci, P., Carotenuto, M., Liso, V., Nosari, A. M., et al. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-11-199406010-00003 · Cited by 139
Kanda, Y., Yamamoto, R., Chizuka, A., Hamaki, T., Suguro, M., Arai, C., Matsuyama, T., Takezako, N., Miwa, A., Kern, W., et al. (2000) · PubMed · Cited by 137
Vardakas, K. Z., Michalopoulos, A. S., & Falagas, M. E. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05727.x · Cited by 129
Bodey, G. P., Anaissie, E. J., Elting, L. S., Estey, E. H., O'Brien, S. M., & Kantarjian, H. M. (1994) · Cancer · doi:10.1002/1097-0142(19940415)73:8<2099::aid-cncr2820730814>3.0.co;2-n · Cited by 127
Schaffner, A., & Schaffner, M. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.4.1035 · Cited by 120
Penack, O., Schwartz, S., Martus, P., Reinwald, M., Schmidt‐Hieber, M., Thiel, E., & Blau, I. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl128 · Cited by 116
Ninane, J. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01974614 · Cited by 114
Philpott‐Howard, J., Wade, J. J., Mufti, G. J., Brammer, K. W., & Ehniniger, G. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.6.973 · Cited by 113
Nucci, M., Biasoli, I., Akiti, T., Silveira, F., Solza, C., Barreiros, G., Spector, N., Derossi, A., & Pulcheri, W. (2000) · Clinical Infectious Diseases · doi:10.1086/313654 · Cited by 113
The prophylactic use of low-dose amphotericin B in bone marrow transplant patients
Riley, D. K., Pavia, A. T., Beatty, P. G., Petersen, F. B., Spruance, J. L., Stokes, R., & Evans, T. G. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90345-x · Cited by 112
Wolff, S., Fay, J. W., Stevens, D. A., Herzig, R. H., Pohlman, B. L., Bolwell, B., Lynch, J., Ericson, S. G., Freytes, C. O., LeMaistre, F. I., et al. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702233 · Cited by 111
Gotzsche, P. C., & Johansen, H. (1997) · BMJ · doi:10.1136/bmj.314.7089.1238 · Cited by 108
Glasmacher, A. G., Cornely, O. A., Ullmann, A. J., Wedding, U., Bodenstein, H., Wandt, H., Boewer, C., Pasold, R., Wolf, H., Hänel, M., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki440 · Cited by 107
Glasmacher, A. G., Hahn, C., Molitor, E., Marklein, G., Sauerbruch, T., & Schmidt‐Wolf, I. G. H. (1999) · Mycoses · doi:10.1046/j.1439-0507.1999.00518.x · Cited by 99
Wingard, J. R., Vaughan, W. P., Braine, H., Merz, W. G., & Saral, R. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90949-1 · Cited by 97
Ellis, M. E., Clink, H. M., Ernst, P., Halim, M. A., Padmos, A., Spence, D. J., Kalin, M., Qadri, S. M. H., Burnie, J., & Greer, W. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02026116 · Cited by 96
Vreugdenhil, G., van Dijke, B. J., Donnelly, J. P., Nováková, I. R. O., Raemaekers, J. M. M., Hoogkamp-Korstanje, M. A. A., Koster, M., & Pauw, B. E. D. (1993) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199309067926 · Cited by 94
Prophylaxis of Oropharyngeal Candidiasis with Fluconazole
Samonis, G., Rolston, K. V. I., Karl, C. L., Miller, P., & Bodey, G. P. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.supplement_3.s369 · Cited by 91
Mattiuzzi, G. N., Estey, E. H., RAAD, I. I., Giles, F. J., Cortes, J. E., Shen, Y., Kontoyiannis, D. P., Koller, C. A., Munsell, M. F., Beran, M., et al. (2003) · Cancer · doi:10.1002/cncr.11094 · Cited by 86
Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients
Laverdière, M., Rotstein, C., Bow, E. J., Roberts, R. S., Ioannou, S., Carr, D., & Moghaddam, N. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.6.1001 · Cited by 82
Goldberg, E., Gafter‐Gvili, A., Robenshtok, E., Leibovici, L., & Paul, M. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.06.040 · Cited by 81
Self-citationRozenberg-Arska, M., Dekker, A. W., Branger, J., & Verhoef, J. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.3.369 · Cited by 79
Shepp, D. H., Klosterman, A. M., Siegel, M. S., & Meyers, J. D. (1985) · The Journal of Infectious Diseases · doi:10.1093/infdis/152.6.1257 · Cited by 76
Prentice, A. G., Warnock, D. W., Johnson, S. A., Taylor, P. C., & Oliver, D. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.4.657 · Cited by 74
Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.
Huijgens, P. C., Simoons‐Smit, A. M., Loenen, A. C. V., Prooy, E., van Tinteren, H., Ossenkoppele, G. J., & Jonkhoff, A. R. (1999) · Journal of Clinical Pathology · doi:10.1136/jcp.52.5.376 · Cited by 74
Fluconazole to prevent yeast infections in bone marrow transplantation patients:
MacMillan, M. L., Goodman, J. L., DeFor, T. E., & Weisdorf, D. J. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01127-5 · Cited by 73
Erjavec, Z., Woolthuis, G., de Vries-Hospers, H. G., Sluiter, W. J., Daenen, S. M. G. J., de Pauw, B., & Halie, M. R. (1997) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01726364 · Cited by 72
Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies
Maertens, J. A. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2006.00805.x · Cited by 71
Oren, I., Rowe, J. M., Sprecher, H., Tamir, A., Benyamini, N., Akria, L., Gorelik, A., Dally, N., Zuckerman, T., Haddad, N., et al. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705418 · Cited by 70
Timmers, G. J., Zweegman, S., Simoons‐Smit, A. M., Loenen, A. C. V., Touw, D. J., & Huijgens, P. C. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702243 · Cited by 70
Koh, L. P., Kurup, A., Goh, Y. T., Fook-Chong, S. M. C., & Tan, P. (2002) · American Journal of Hematology · doi:10.1002/ajh.10234 · Cited by 67
Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis
Beyer, J., Barzen, G., RISSE, G., Weyer, C., Miksits, K., Dullenkopf, K., Huhn, D., & Siegert, W. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.6.1367 · Cited by 66
Efficacy of ketoconazole v nystatin in prevention of fungal infections in neutropenic patients.
Jones, P. G., Kauffman, C. A., McAuliffe, L. S., Liepman, M. K., & Bergman, A. G. (1984) · PubMed · Cited by 63
Gøtzsche, P. C., & Johansen, H. K. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000026.pub2 · Cited by 63
German AML Cooperative Group, Kern, W., Behre, G., Rudolf, T., Kerkhoff, A., Grote‐Metke, A., Eimermacher, H., Kubica, U., Wormann, B. J., B�chner, T., et al. (1998) · Cancer · Cited by 62
The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients
Chandrasekar, P. H., & Gatny, C. M. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.2.309 · Cited by 62
Alexander, B. D., Ashley, E. S. D., Addison, R. M., Alspaugh, J. A., Chao, N. J. A., & Perfect, J. R. (2006) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2006.00125.x · Cited by 60
Problems in the Diagnosis of Invasive Fungal Diseases
Rinaldi, M. G. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.3.493 · Cited by 60
Tollemar, J. G., Ringdén, O. T. H., Andersson, S., Sundberg, B., Ljungman, P. T., Sparrelid, E., & Tydén, G. (1993) · PubMed · Cited by 56
Boogaerts, M. A., Maertens, J., van Hoof, A., de Bock, R., Fillet, G., Peetermans, M., Selleslag, D., Vandercam, B., Vandewoude, K., Zachée, P., et al. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.97 · Cited by 55
Martino, R., & Viscoli, C. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05838.x · Cited by 54
Pharmacokinetics of Itraconazole Oral Solution in Neutropenic Children during Long-Term Prophylaxis
Schmitt, C., Pérel, Y., Harousseau, J., Lemerle, S., Chwetzoff, E., Moing, J. P. L., & Levron, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1561-1564.2001 · Cited by 51
Gøtzsche, P. C., & Johansen, H. K. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000026 · Cited by 51
Effect of Fluconazole Prophylaxis on Fever and Use of Amphotericin in Neutropenic Cancer Patients
Chandrasekar, P. H., Gatny, C. M., & Bone Marrow Transplantation Team (2009) · Chemotherapy · doi:10.1159/000239184 · Cited by 50
Böhme, A., Just‐Nübling, G., Bergmann, L., SHAH, P. M., Stille, W., & Hoelzer, D. T. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.6.953 · Cited by 49
Efficacy of different prophylactic antifungal regimens in bone marrow transplantation.
Annaloro, C., Oriana, A., Tagliaferri, E., Bertolli, V. G., Volpe, A. D., Soligo, D. A., Ibatici, A., Pozzoli, E. F., & Deliliers, G. L. (1995) · PubMed · Cited by 49
Efficacy of Ketoconazole v Nystatin in Prevention of Fungal Infections in Neutropenic Patients
Jones, P. G. (1984) · Archives of Internal Medicine · doi:10.1001/archinte.1984.00350150149034 · Cited by 48
Palmblad, J. E. W., Lönnqvist, B., Carlsson, B., Grimfors, G., Järnmark, M., Lerner, R., Ljungman, P. T., Nyström-Rosander, C., Petrini, B., & Öberg, G. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00945.x · Cited by 46
Groll, A. H. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.6.855 · Cited by 46
Mattiuzzi, G. N., Kantarjian, H. M., Faderl, S. H., Lim, J. T., Kontoyiannis, D. P., Thomas, D. A., Wierda, W. G., Raad, I. I., Garcia‐Manero, G., Zhou, X., et al. (2004) · Cancer · doi:10.1002/cncr.11936 · Cited by 46
Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy
Epstein, J. B., Truelove, E., Huggins, K. H., Mancl, L., Chen, A., Press, O. W., Petersdorf, S., Fritsche, T. R., & Epstein, J. (2004) · Supportive Care in Cancer · doi:10.1007/s00520-004-0634-1 · Cited by 46
Cuttner, J., Troy, K. M., Funaro, L., Brenden, R. A., & Bottone, E. J. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90342-6 · Cited by 44
Lass‐Flörl, C., Gunsilius, E., GASTL, G. A., Englisch, M., Koch, G., Ulmer, H., Dierich, M. P., & Petzer, A. (2003) · Annals of Hematology · doi:10.1007/s00277-003-0666-5 · Cited by 43
Voriconazole versus amphotericin B in cancer patients with neutropenia
Jørgensen, K. J., Gøtzsche, P. C., & Johansen, H. K. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004707.pub2 · Cited by 43
Bradford, C. R., Prentice, A., Warnock, D. W., & Copplestone, J. A. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/28.4.555 · Cited by 41
Glasmacher, A. G., Cornely, O. A., Orlopp, K. S., Reuter, S., Blaschke, S., Eichel, M., Silling, G., Simons, B., Egerer, G., Siemann, M., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki410 · Cited by 41
Management of Fungal Infection in Neutropenic Patients with Fluconazole
Brammer, K. W. (1990) · Hämatologie und Bluttransfusion · doi:10.1007/978-3-642-74643-7_97 · Cited by 40
Young, G. A. R., Bosly, A., Gibbs, D. L., & Durrant, S. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00102-1 · Cited by 39
Egger, T., Gratwohl, A. A., Tichelli, A., Uhr, M., Gysi, C. S., Passweg, J. R., Pless, M., Wernli, M., Buser, U., Wuhrmann, J., et al. (1995) · Supportive Care in Cancer · doi:10.1007/bf00365855 · Cited by 39
Prophylaxis of Fungal Infections with Itraconazole during Remission‐Induction Therapy
Prentice, A., & Bradford, G. R. (1989) · Mycoses · doi:10.1111/j.1439-0507.1989.tb02298.x · Cited by 38
Meunier, F., Aoun, M., Janssens, M., Dekoster, C., & Paesmans, M. (1991) · Clinical Drug Investigation · doi:10.1007/bf03259575 · Cited by 33
Tollemar, J. G., Höckerstedt, K., Bg, E., Sundberg, B., & Ringdén, O. T. H. (1994) · PubMed · Cited by 32
Uhlenbrock, S., Zimmermann, M., Fegeler, W., Jürgens, H., & Ritter, J. (2001) · Mycoses · doi:10.1046/j.1439-0507.2001.00706.x · Cited by 31
Benhamou, E., Hartmann, O., Noguès, C., Maraninchi, D., Valteau‐Couanet, D., & Lemerle, J. (1991) · PubMed · Cited by 31
Lamy, T., Bernard, M., Courtois, A., Jacquelinet, C., Chevrier, S., Dauriac, C., Grulois, I., Guiguen, C., & Prise, P. L. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809050939 · Cited by 29
Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia
Kaptan, K., Ural, A. U., Çetin, T., Avcu, F., Beyan, C., & Yalçın, A. (2003) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-002-0207-5 · Cited by 27
Mücke, R., Kaben, U., Libera, T., Knauerhase, H., Ziegler, P.-G., Hamann, D., & Strietzel, M. (1998) · Mycoses · doi:10.1111/j.1439-0507.1998.tb00364.x · Cited by 27
Akiyama, H., Mori, S., Tanikawa, S., Sakamaki, H., & ONOZAWA, Y. (1993) · Mycoses · doi:10.1111/j.1439-0507.1993.tb00725.x · Cited by 26
Grigg, A., Brown, M., Roberts, A. W., Szer, J., & Slavin, M. A. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704614 · Cited by 24
Ellis, M. E., Halim, M. A., Spence, D., Ernst, P., Clink, H. M., Kalin, M., Baillie, F., & Greer, W. (1995) · Journal of Infection · doi:10.1016/s0163-4453(95)80009-3 · Cited by 23
Intensive Intravenous Amphotericin B for Prophylaxis of Systemic Fungal Infections
Karthaus, M., Doellmann, T., Klimasch, T., Elser, C., Rosenthal, C., Ganser, A., & Heil, G. (2000) · Chemotherapy · doi:10.1159/000007301 · Cited by 21
Glasmacher, A. G., & Prentice, A. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01609.x · Cited by 18
Antifungal Prophylaxis in Severely Neutropenic Patients: How Much Fluconazole is Necessary?
van Delden, C., Lew, D. P., Chapuis, B., Rohner, P., & Hirschel, B. J. (1995) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1995.tb00020.x · Cited by 18
Wingard, J. R. (2004) · Clinical Infectious Diseases · doi:10.1086/421953 · Cited by 18
Schaison, G., Baruchel, A., & Arlet, G. (1990) · British Journal of Haematology · doi:10.1111/j.1365-2141.1990.tb07931.x · Cited by 18
The Cost of Treating Systemic Fungal Infections
van Gool, R. (2001) · Drugs · doi:10.2165/00003495-200161001-00005 · Cited by 17
Oral candidiasis prevention in transplantation patients: a comparative study
Elad, S., Wexler, A., Garfunkel, A. A., Shapira, M. Y., Bitan, M., & Or, R. (2006) · Clinical Transplantation · doi:10.1111/j.1399-0012.2005.00484.x · Cited by 14
Itraconazole in Neutropenic Patients
Wout, J. W. V. (2009) · Chemotherapy · doi:10.1159/000239049 · Cited by 14
Krñger, W., Stockschläder, M., Sobottka, I., Betker, R., de Wit, M., Kröger, N. M., Grimm, J., Arland, M., Fiedler, W., Erttmann, R., et al. (1997) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199709055586 · Cited by 12
Fluconazole in the prophylaxis of fungal infection after bone marrow transplantation
Ehninger, G., Schuler, H. K., & Sarnow, E. (1996) · Mycoses · doi:10.1111/j.1439-0507.1996.tb00135.x · Cited by 8
Cited by
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Döhner, H., Estey, E. H., Amadori, S., Appelbaum, F. R., Büchner, T., Burnett, A. K., Dombret, H., Fenaux, P., Grimwade, D., Larson, R. A., et al. (2010) · Blood · doi:10.1182/blood-2009-07-235358 · Cited by 3,373
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq147 · Cited by 704
Taplitz, R. A., Kennedy, E. B., Bow, E. J., Crews, J., Gleason, C., Hawley, D. K., Langston, A. A., Nastoupil, L. J., Rajotte, M., Rolston, K. V., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.18.00374 · Cited by 601
Maertens, J., Marchetti, O., Herbrecht, R., Cornely, O. A., Flückiger, U., Frêre, P., Gachot, B., Heinz, W. J., Lass-Flörl, C., Ribaud, P., et al. (2011) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.175 · Cited by 470
Metadata
- Authors
- Robenshtok, E., Gafter-Gvili, A., Goldberg, E., Weinberger, M., Yeshurun, M., Leibovici, L., & Paul, M.
- Venue
- Journal of Clinical Oncology
- Published
- 2007-12-01
- Volume
- 25
- Issue
- 34
- Pages
- 5471-5489
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2057220915
- Cited by
- 298
- References
- 115
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.